Named Patient Import
Import life-saving medicines not yet approved in India under the regulatory Named Patient Import program by CDSCO.
What is Named Patient Import?
Named Patient Import allows patients or healthcare providers in India to legally import unapproved or investigational medicines from overseas, on a case-by-case basis, with necessary regulatory approvals from CDSCO.
This program is especially crucial for accessing life-saving treatments when no alternative therapies are available domestically.
How We Facilitate Named Patient Import
Regulatory Guidance
Assistance with CDSCO approvals and documentation.
Assistance with CDSCO approvals and documentation.
Secure Global Sourcing
Verified suppliers and manufacturers globally.
Verified suppliers and manufacturers globally.
Fast Turnaround
Expedite sourcing to meet urgent patient needs.
Expedite sourcing to meet urgent patient needs.
Compliance & Safety
Strict adherence to Indian import regulations.
Strict adherence to Indian import regulations.
Who Can Request Named Patient Import?
- Patients with life-threatening conditions
- Hospitals & Specialty Clinics
- Authorized healthcare professionals
- Regulatory agents & legal representatives
Need to import a medicine under the Named Patient program?
Submit Your Named Patient RFPFrequently Asked Questions
Named Patient Import allows patients or doctors in India to import medicines not yet approved in India. It requires permission from CDSCO.
Patients, healthcare providers, and authorized representatives can apply for this import.
Approval times vary but usually take several weeks depending on the medicine and documentation.
Imported medicines must follow Indian regulations. They come from licensed suppliers overseas.
Only medicines not available or approved in India and needed for specific patient cases qualify.
Usually, a doctor’s prescription, patient details, and an application to CDSCO are required.
